GSK was able to avert industrial action at some of its UK facilities last year after agreeing a pay deal – but with the cost-of-living crisis still in full swing, the issue has returned to the fore.

After months of delay, GlaxoSmithKline has agreed a deal with the UK government that will allow its meningitis B (MenB) vaccine Bexsero to be added to the NHS' routine childhood immunisation schedule.